Revass Utama Medika

What Revass Utama Medika does

PT Revass Utama Medika is an Indonesia-based medical device distribution company founded in 2010, specializing in cardiology intervention and critical care devices. It distributes a portfolio spanning drug-eluting stents (EucaLimus), balloon dilatation catheters (Sapphire NC24, Scoreflex, Scoreflex TRIO), paclitaxel-coated PTCA catheters, guide extension and microcatheters (Xtenza, Teleport XT), congenital heart defect occluders and snares (Memopart line), the Diamondback 360 orbital atherectomy system, and the MultiFiltratePRO CRRT platform with Ci-Ca regional citrate anticoagulation. The company operates through two wholly-owned subsidiaries — Lumina Utama Medika (high-tech cardiovascular devices for national referral hospitals and accredited heart centers) and Kedung Artha Medika (complementary cardiovascular devices and access tools for regional and developing hospitals).

Revass generates revenue on a transaction-fee distribution model, sourcing products from global principals including OrbusNeich (sole distributor since 2010), Lepu Medical, Abbott Vascular, Fresenius Medical Care, Terumo, BenQ Medical, APT Medical, Concept Medical, Frisch Medical, and Wego Medical, and selling to hospitals equipped with cardiac catheterization labs and ICU/critical care units. The company serves more than 300 hospitals across 60 major cities and 32 provinces, reaching approximately 93–95% of Indonesian hospitals with cath labs, and runs direct field sales supported by clinical specialist teams, medical education workshops (including collaborations with National Cardiovascular Center Harapan Kita), and a CDAKB-certified warehouse and distribution network. Reported revenue growth has been 40% (2021), 55% (2022), 36% (2023), approximately 40% year-to-date as of June 2025, and 33% as referenced at NSC 2026.

Since November 27, 2023, Revass has been an 84%-owned indirect subsidiary of OrbusNeich Medical Group Holdings Limited (Hong Kong), with the remaining minority stake held by local shareholders including M. Zidni Ilma. The company is led by President Director Andriatno Martono, with OrbusNeich executives (David Chien, Denise Lau, Jason Chen) serving in commissioner and director capacities. Revass holds CDAKB, ISO 13485:2016, ISO 9001:2015, and ISO 37001:2016 certifications, and was certified as a Great Place to Work in 2025 (87% trust score) and recertified in 2026 (86%). In 2024–2025, the company opened a new East Jakarta headquarters (August 2025) and a Sidoarjo branch office (September 2025), and established the two operating subsidiaries noted above.

Name

Revass Utama Medika

Legal name

PT Revass Utama Medika

Website

https://revassutamamedika.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

101–250 employees

Short description

PT Revass Utama Medika is an Indonesia-based medical device distributor founded in 2010, specializing in cardiology intervention and critical care devices. It serves 300+ hospitals across 32 provinces as the 84%-owned subsidiary of OrbusNeich Medical Group, distributing stents, balloons, occluders, and CRRT systems from global principals.

Ownership category

akta.pro rank

Headquarters

HQ city

Dki Jakarta

HQ country

Indonesia

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Medical Device Distribution: Distribution and marketing of cardiology intervention medical devices across Indonesia, serving hospitals with catheterization labs and cardiac centers
2. Principal Product Distribution: Distribution of products from global principals including OrbusNeich, Lepu Medical, Abbott Vascular, Fresenius Medical Care, and others

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

PT Revass Utama Medika is a medical device distributor that imports and markets cardiology intervention devices in Indonesia, including drug-eluting stents, balloon dilatation catheters, atherectomy systems, microcatheters, guide extension catheters, congenital heart defect occluders, and CRRT systems. The company sources these products from global principals such as OrbusNeich, Lepu Medical, Abbott Vascular, and Fresenius Medical Care, and distributes them to more than 300 hospitals across 60 major cities through direct sales, clinical specialist support, and after-sales service.

Product overview

PT Revass Utama Medika is a medical device distributor, not a software product company. The company distributes a comprehensive portfolio of cardiology intervention devices organized into five product categories: (1) Coronary Intervention - including EucaLimus drug-eluting stents, Scoreflex/Scoreflex TRIO/Sapphire NC24/Sapphire 3/Sapphire 3 balloon dilatation catheters, SUPPORT C paclitaxel-coated PTCA catheters, Teleport XT microcatheters, and Xtenza guide extension catheters; (2) Peripheral Interventions - Jade and Scoreflex peripheral balloons; (3) Congenital Heart Disease - Memopart occluder devices (ASDO, PDAO, VSDO) with MemoPart snare and ODS delivery system; (4) Intensive Care - MultiFiltratePRO CRRT system with Ci-Ca regional citrate anticoagulation and Body Composition Monitor (BCM); (5) Cardiovascular Accessories - guidewires, introducers, and PCI/CAG support devices. The company operates through two subsidiaries - Lumina Utama Medika (high-tech cardiovascular devices) and Kedung Artha Medika (complementary cardiovascular support devices).

Differentiator

Problem solved

Functional benefit

Products and services

• EucaLimus Coronary Stent

Quantifiable outcome

• Serves 93-95% of hospitals with cardiac catheterization labs in Indonesia
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

17 partnerships are on record, tiered minor, core and flagship.

• Palang Merah Indonesia (PMI) Kota BekasiminorOthers · 29 April 2026Collaboration for Revassian Donor blood donation program, held twice yearly as part of corporate social responsibility initiatives.
• National Cardiovascular Center Harapan KitacoreStrategic or Co-development Partner · 28 April 2026Revass Group, through PT Lumina Utama Medika, collaborated with National Cardiovascular Center Harapan Kita for the Workshop on Expert Approaches to Transcatheter ASD and PFO Closure and OAS Diamondback 360 Workshop, supporting advanced education in structural heart interventions.
• TerumocoreChannel Partner/ Reseller/ Distributor · 1 January 2025Partnership for DNA Solution products since 2025.
• PugaominorChannel Partner/ Reseller/ Distributor · 1 January 2024Distributor of products including PGGuider, PGCathater, Smart Pioneer since 2024.
• Skynor MedicalminorChannel Partner/ Reseller/ Distributor · 1 January 2024Distributor of Skyflow Thrombectomy Device since 2024.
• MinimaxminorChannel Partner/ Reseller/ Distributor · 1 January 2024Distributor of Radiofrequency Ablation Instrument since 2024.
• Bartec GroupminorChannel Partner/ Reseller/ Distributor · 1 January 2024Distributor of Angiodrape products since 2024.
• Wego MedicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2023Partnership established in 2023 for neurovascular products including Coil and Visee.
• Fresenius Medical CarecoreChannel Partner/ Reseller/ Distributor · 1 January 2022Partnership for critical care products including Continuous Renal Replacement Therapy (CRRT) and Body Composition Monitoring (BCM) since 2022.
• Ronas (Korea)minorChannel Partner/ Reseller/ Distributor · 1 January 2022Entered beauty and aesthetic market collaboration with Ronas Korea in 2022, expanding service portfolio.
• Frisch MedicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2021Distributor of stent Evrolimus (Evrosure) and drug coating balloon (Mamba) since 2021.
• Abbott VascularcoreChannel Partner/ Reseller/ Distributor · 1 January 2020Authorized distributor of atherectomy systems including Diamondback 360 and Stealth 360 since 2020.
• APT MedicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2018Authorized distributor of accessories including catheters and guidewires since 2018.
• Lepu MedicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2016Authorized distributor of occluder products (Memopart) and PCI accessories (Introducer, Guide Wire, etc.) since 2016. Recognized as Best Partner in Indonesia in 2025.
• BenQ Medical (Anscare)coreChannel Partner/ Reseller/ Distributor · 1 January 2015Authorized distributor of accessory products since 2015, expanding Revass' product portfolio.
• OrbusNeichflagshipOEM/ Whitelabel/ Licensing Partner · 1 January 2010Sole distributor for coronary vascular products including stents (Combo, Azzule) and balloons (Sapphire, Scoreflex), and peripheral products (Jade, Scoreflex) since 2010. Became majority-owned subsidiary in 2023.
• Concept MedicalcoreChannel Partner/ Reseller/ DistributorDistributor of drug coating balloons including Magictouch and DCB PTA products.

Scale indicators12 records

Recent moves11 records

Expansion highlights7 records

Direct peers

• PT Cardia Medikal Indonesia: Indonesia-based interventional cardiology device distributor; competes with Revass for hospital contracts on stents, balloons, and structural heart products.
• PT Transmedic Indonesia: Distributor of advanced medical devices including cardiology and critical care products to Indonesian hospitals; competes with Revass in cath-lab and ICU segments.
• Andra Health Group: Indonesian medical device distributor specializing in cardiology and hospital products; one of Revass's closest direct competitors for cath-lab and OR accounts.

Broad incumbents

• Terumo (Asia): Japanese global med-device manufacturer with interventional cardiology and adjacent products; Revass has become a Terumo distributor since 2025, and Terumo also runs its own APAC distribution overlapping Indonesia.
• Abbott Vascular (Asia Pacific): Major interventional cardiology principal that Revass distributes for in Indonesia (Diamondback 360 atherectomy); globally scaled incumbent whose channel strategy directly shapes Revass's portfolio.
• Boston Scientific (Indonesia): Global interventional cardiology manufacturer with its own Indonesia sales channel; competes indirectly as both an overlapping product principal and a competing direct-sales footprint.
• GE HealthCare (Indonesia): Global medical device manufacturer with local distribution of imaging and cardiology equipment; broader portfolio player whose Indonesia channel occasionally overlaps with Revass on cardiovascular accounts.
• Medtronic (Indonesia): Global leader in interventional cardiology with established Indonesia distribution; competes with Revass on cath-lab accounts and represents the kind of principal whose distribution decisions drive Revass's trajectory.
• Fresenius Medical Care (Indonesia): Global critical care/dialysis manufacturer partner of Revass; comparable as a critical-care equipment principal with significant Indonesia presence, illustrating the principal-distributor dynamic Revass operates within.

Regional players

• Endo-Flex (Indonesia): Indonesian cardiology/peripheral device distributor serving hospital cath labs; directly comparable mid-tier local distributor competing for the same hospital channel as Revass.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookweb.facebook.com/ptrevassutamamedika
• LinkedInlinkedin.com/company/revass-utama-medika/mycompany/?viewAsMember=true
• Instagraminstagram.com/revassutamamedika
• TikToktiktok.com/@revassutamamedika

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Revass Utama Medika